These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21381732)

  • 1. Rational design of β-sheet ligands against Aβ42-induced toxicity.
    Hochdörffer K; März-Berberich J; Nagel-Steger L; Epple M; Meyer-Zaika W; Horn AH; Sticht H; Sinha S; Bitan G; Schrader T
    J Am Chem Soc; 2011 Mar; 133(12):4348-58. PubMed ID: 21381732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
    Viet MH; Ngo ST; Lam NS; Li MS
    J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Sheet ligands in action: KLVFF recognition by aminopyrazole hybrid receptors in water.
    Rzepecki P; Schrader T
    J Am Chem Soc; 2005 Mar; 127(9):3016-25. PubMed ID: 15740139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
    Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
    Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.
    LeVine H
    Arch Biochem Biophys; 1997 Jun; 342(2):306-16. PubMed ID: 9186492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced flocculation of neurotoxic fibrillar Abeta(1-42) by noncovalent crosslinking.
    Hetényi A; Fülöp L; Martinek TA; Wéber E; Soós K; Penke B
    Chembiochem; 2008 Mar; 9(5):748-57. PubMed ID: 18283694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
    Chen Z; Krause G; Reif B
    J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity.
    Feng Y; Yang SG; Du XT; Zhang X; Sun XX; Zhao M; Sun GY; Liu RT
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1250-4. PubMed ID: 19878655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Alzheimer's disease-associated Abeta aggregation by rationally designed nonpeptidic beta-sheet ligands.
    Rzepecki P; Nagel-Steger L; Feuerstein S; Linne U; Molt O; Zadmard R; Aschermann K; Wehner M; Schrader T; Riesner D
    J Biol Chem; 2004 Nov; 279(46):47497-505. PubMed ID: 15322133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
    Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
    Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
    Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
    Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
    Sciarretta KL; Boire A; Gordon DJ; Meredith SC
    Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
    Saraiva AM; Pereira MC; Brezesinski G
    Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
    Yoshiike Y; Akagi T; Takashima A
    Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.